Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SoLá Pelvic Therapy is a proprietary, FDA-cleared, non-invasive Class IV near-infrared photobiomodulation laser system for the treatment of chronic pelvic pain and related conditions. Over 3,500–5,000 procedures have been performed with no serious adverse events reported. Clinical data show rapid and significant reduction in pelvic pain symptoms—over 80% of treated women achieve improvement within two weeks. The device collects real-world patient-reported outcomes at every treatment to support ongoing analysis and optimization[1][3][4][8].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SoLá Pelvic Therapy.